Archive
Christian Rüegg appointed new Director of the Paul Scherrer Institute
On 27 November 2019, at the recommendation of the ETH Board, the Federal Council has appointed Christian Rüegg as the new director of the Paul Scherrer Institute PSI. The 43-year-old will take over from Thierry Strässle, who has headed the institute on an interim basis since the beginning of the year. Mr Rüegg is currently head of the Neutrons and Muons Division at the PSI. He will take up his new position on 1 April 2020.
Brilliant medicines
In the service of health, scientists at the Paul Scherrer Institute PSI work with radionuclides and develop agents to treat cancer and to detect tumours. Their research provides support to hospitals and is of great interest to Swiss industry.
Radionuclides for cancer therapy are in great demand
Radionuclides open up new options for treating cancer. Christian Rüegg, head of the Research with Neutrons and Muons Division at PSI, explains the significance of the Swiss Spallation Neutron Source SINQ at PSI.
Cancer medicine using PSI’s neutron source
At the neutron source SINQ, PSI researchers are producing special radionuclides that aid in the development of new and more effectively targeted cancer therapies. In this they collaborate closely with the clinics in the surrounding area.
A fast and precise look into fibre-reinforced composites
Researchers at the Paul Scherrer Institute PSI have developed a new process with which fibre-reinforced composite materials can be precisely X-rayed. This could help to develop better materials with novel properties.
On the way to intelligent microrobots
It is reminiscent of a paper bird made with the help of the Japanese folding art origami: a microrobot that uses the force of magnetic fields to move. In the future, such small machines could be used, for example, in medical operations.